Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
117.46
+0.06 (+0.05%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
90
91
Next >
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
Today 12:01 EDT
BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these innovative treatments face challenges in cost, scalability, and...
Via
Benzinga
Exposures
COVID-19
Merck Pulls Plug On Two Keytruda Late-Stage Studies On Underwhelming Data
Today 10:35 EDT
Merck discontinues two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630, for Keytruda in lung cancer and cutaneous squamous cell carcinoma. Independent committees found no survival benefit and higher...
Via
Benzinga
Merck to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Today 6:45 EDT
From
Merck & Co., Inc.
Via
Business Wire
Merck Provides Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials
Today 6:30 EDT
From
Merck & Co., Inc.
Via
Business Wire
Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry
August 28, 2024
Via
Benzinga
NYSE:MRK is probably undervalued for the fundamentals it is displaying.
August 28, 2024
MERCK & CO. INC. (NYSE:MRK) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Dow Jones Industrial Average Pares Recent Gains As Investors Take A Pause
August 28, 2024
The Dow Jones Industrial Average (DJIA) trimmed near-term gains on Wednesday, backsliding 150 points in the midweek market session.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
12 Dividend Stocks to Earn Income Every Month
August 28, 2024
Get paid a dividend on a monthly basis.
Via
The Motley Fool
Options: An Unlikely Source Of Income
August 27, 2024
Calls give the buyer the right, but not the obligation, to buy a stock at a specific price by a specific date. The seller of the call must deliver the stock if the buyer requests it.
Via
Talk Markets
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
August 27, 2024
There's no reason to succumb to gloom and doom here.
Via
The Motley Fool
Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the Treatment of Certain Patients With Essential Thrombocythemia
August 27, 2024
From
Merck & Co., Inc.
Via
Business Wire
Merck & Co's Options: A Look at What the Big Money is Thinking
August 26, 2024
Via
Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking
August 19, 2024
Via
Benzinga
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III
August 26, 2024
From
Merck & Co., Inc.
Via
Business Wire
Week In Review: Multitude Out-Licenses Tissue Factor ADC To Adcendo In $1 Billion Deal
August 24, 2024
Shanghai Multitude Therapeutics out-licensed global rights for its Tissue Factor ADC to Adcendo in a $1 billion agreement. The value of the agreement includes upfront and milestone payments, with...
Via
Talk Markets
MarketBeat Week in Review – 8/19 - 8/23
August 24, 2024
Stocks closed the week higher on the near certainty that the Fed will cut interest rates in September, but in the short term, all eyes are on NVDA earnings
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry
August 14, 2024
Via
Benzinga
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
August 23, 2024
The FDA's Oncologic Drugs Advisory Committee will meet on September 26 to reevaluate the approvals of checkpoint inhibitors for advanced gastric, gastroesophageal junction adenocarcinoma, and...
Via
Benzinga
Exposures
Product Safety
Merck's Ebola Vaccine Showed 84% Effectiveness During Large Outbreak In Africa
August 22, 2024
Merck's rVSV-ZEBOV vaccine, the only WHO-prequalified vaccine for Ebola outbreaks caused by the Zaire ebolavirus, is FDA-approved for adults and children. A study on the 2018–20 Congo outbreak shows...
Via
Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Via
Talk Markets
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
August 20, 2024
Global big pharmaceutical company Merck & Co. Inc. (NYSE: MRK) shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates,
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
August 19, 2024
Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release.
Via
MarketBeat
Exposures
COVID-19
Product Safety
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
August 18, 2024
This list of top-selling drugs could look drastically different in a few years.
Via
The Motley Fool
Biden Administration Targets $6B Savings Through Medicare Drug Price Negotiations
August 15, 2024
Medicare drug price negotiations, enabled by the Inflation Reduction Act, are set to save the U.S. government $6 billion.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
August 15, 2024
The unveiled prices follow months of back-and-forth negotiation between the government and the companies.
Via
Investor's Business Daily
2 Dow Jones Stocks to Buy Hand Over Fist Right Now
August 15, 2024
Despite a possible recession, these two Dow Jones stocks are still a buy.
Via
The Motley Fool
Topics
Economy
Stocks
Exposures
Economy
US Equities
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
August 14, 2024
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Via
InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
August 09, 2024
Merck has agreed to acquire CN201, a bispecific antibody from Curon Biopharmaceutical, for $700 million. This acquisition aims to advance Merck's pipeline for treating B-cell malignancies and...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
90
91
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.